Results 271 to 280 of about 1,894,460 (329)

Role of Regulatory T Cells in Chronic Obstructive Pulmonary Disease. [PDF]

open access: yesPulm Med
Sampath M   +5 more
europepmc   +1 more source

T-regulatory-1 (TR1) cells prevent colitis induced by enteric bacterial antigen-reactive pathogenic TH1 cells

open access: bronze, 2000
Yingzi Cong   +4 more
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Migration of Regulatory T Cells to the Peritumor Microenvironment of Experimental Glioblastoma. [PDF]

open access: yesSovrem Tekhnologii Med
Yanysheva EP   +5 more
europepmc   +1 more source

ADMINISTRATION OF A NEW SUBSET OF DENDRITIC CELLS PROPAGATED FROM MOUSE LIVERS PROLONGS CARDIAC ALLOGRAFT SURVIVAL BY DIFFERENTIATION OF T REGULATORY CELLS.

open access: bronze, 2000
Lina Lu   +8 more
openalex   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Permissive immunosuppression facilitates the expansion of ex vivo administered regulatory T cells in the lung allograft. [PDF]

open access: yesSci Rep
Takahagi A   +10 more
europepmc   +1 more source

Characterizing epithelial‐mesenchymal transition‐linked heterogeneity in breast cancer circulating tumor cells at a single‐cell level

open access: yesMolecular Oncology, EarlyView.
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy